PRTA

Prothena Corporation (PRTA)

About Prothena Corporation (PRTA)

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Details

Daily high

$10.16

Daily low

$9.52

Price at open

$9.95

52 Week High

$17.66

52 Week Low

$4.32

Market cap

536.7M

Dividend yield

0.00%

Volume

638,928

Avg. volume

609,332

P/E ratio

-1.91

Prothena Corporation News